Bart Biemond
Overview
Explore the profile of Bart Biemond including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
50
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Buil J, Huygens S, Dunbar A, Schauwvlieghe A, Reynders M, Langerak D, et al.
J Clin Microbiol
. 2023 Apr;
61(5):e0004423.
PMID: 37097150
Galactomannan (GM) testing of bronchoalveolar lavage (BAL) fluid samples has become an essential tool to diagnose invasive pulmonary aspergillosis (IPA) and is part of diagnostic guidelines. Enzyme-linked immunosorbent assays (ELISAs)...
2.
van Vuren A, Kerkhoffs J, Schols S, Rijneveld A, Nur E, Peereboom D, et al.
Am J Hematol
. 2022 Apr;
97(7):924-932.
PMID: 35472008
Iron overload is a severe general complication of hereditary anemias. Treatment with iron chelators is hampered by important side-effects, high costs, and the lack of availability in many countries with...
3.
Gerritsma J, Bongaerts V, Eckhardt C, Heijboer H, Nur E, Biemond B, et al.
Br J Haematol
. 2021 Oct;
196(3):769-776.
PMID: 34632580
Delayed haemolytic transfusion reaction (DHTR) is a potentially life-threatening complication of red blood cell (RBC) transfusions in sickle cell disease (SCD) and is classically induced by reactivation of previously formed...
4.
Janssen J, Lowenberg B, Manz M, Bargetzi M, Biemond B, Borne P, et al.
Cancers (Basel)
. 2021 Feb;
13(4).
PMID: 33562393
Treatment results of AML in elderly patients are unsatisfactory. We hypothesized that addition of tosedostat, an aminopeptidase inhibitor, to intensive chemotherapy may improve outcome in this population. After establishing a...
5.
Pabst T, Vellenga E, van Putten W, Schouten H, Graux C, Vekemans M, et al.
Blood
. 2012 Mar;
119(23):5367-73.
PMID: 22422824
The clinical value of chemotherapy sensitization of acute myeloid leukemia (AML) with G-CSF priming has remained controversial. Cytarabine is a key constituent of remission induction chemotherapy. The effect of G-CSF...